Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |